Histological Evidence of Tumour Rejection After Active Immunotherapy in Human Malignant Disease
- 22 April 1972
- Vol. 2 (5807) , 183-188
- https://doi.org/10.1136/bmj.2.5807.183
Abstract
Active immunotherapy with multiple doses of tumour homogenate incorporated in complete Freund adjuvant was used to treat 12 patients with advanced malignant disease. Evidence of some tumour destruction was observed in 10. Improvement in general clinical condition and the disappearance of symptoms referable to tumour occurred in seven of the patients. The duration of improvement varied considerably. Histological evidence of lymphocytic infiltration, necrosis, and fibrous replacement of tumour tissue is presented.Keywords
This publication has 23 references indexed in Scilit:
- Immunological treatment of leukaemias.BMJ, 1970
- Colony inhibition studies on blocking and non‐blocking serum effects on cellular immunity to moloney sarcomasInternational Journal of Cancer, 1970
- Active immunotherapy in treatment of acute leukaemiaBMJ, 1969
- Cellular and Humoral immunity to Different Types of Human NeoplasmsNature, 1968
- A NEW METHOD OF ACTIVE IMMUNISATION TO AUTOLOGOUS HUMAN TUMOUR TISSUEThe Lancet, 1967
- Clinical Immunologic Study of Malignant DiseaseAnnals of Surgery, 1966
- The role of the reticuloendothelial system in the host reaction to neoplasia.1961
- STUDIES IN TUMOR AUTO-IMMUNITY1960
- DEMONSTRATION OF RESISTANCE AGAINST METHYLCHOLANTHRENE-INDUCED SARCOMAS IN THE PRIMARY AUTOCHTHONOUS HOST1960
- THE EFFECT OF PRIOR INJECTIONS OF TISSUE ANTISERUMS ON THE SURVIVAL OF CANCER HOMOIOGRAFTS IN MICE1952